Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

On high-risk, low-grade glioma: What distinguishes high from low?

Geurts M, van den Bent MJ.

Cancer. 2019 Jan 15;125(2):174-176. doi: 10.1002/cncr.31834. Epub 2018 Dec 4. No abstract available.

PMID:
30512190
2.

Malignant Transformation in Glioma Steered by an Angiogenic Switch: Defining a Role for Bone Marrow-Derived Cells.

Xu R, Pisapia D, Greenfield JP.

Cureus. 2016 Jan 27;8(1):e471. doi: 10.7759/cureus.471. Review.

3.

Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.

Jansen NL, Suchorska B, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, Drexler M, Bartenstein P, Schnell O, Tonn JC, Thon N, Kreth FW, la Fougère C.

J Nucl Med. 2014 Feb;55(2):198-203. doi: 10.2967/jnumed.113.122333. Epub 2013 Dec 30.

4.

Survival and low-grade glioma: the emergence of genetic information.

Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M.

Neurosurg Focus. 2015 Jan;38(1):E6. doi: 10.3171/2014.10.FOCUS12367.

5.

High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.

Guan Y, Chen L, Bao Y, Qiu B, Pang C, Cui R, Wang Y.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6576-88. eCollection 2015.

6.

Lower apparent diffusion coefficients indicate distinct prognosis in low-grade and high-grade glioma.

Cui Y, Ma L, Chen X, Zhang Z, Jiang H, Lin S.

J Neurooncol. 2014 Sep;119(2):377-85. doi: 10.1007/s11060-014-1490-6. Epub 2014 May 30.

PMID:
24874469
7.

Chemotherapy in glioma.

Taal W, Bromberg JE, van den Bent MJ.

CNS Oncol. 2015;4(3):179-92. doi: 10.2217/cns.15.2. Epub 2015 Apr 23. Review.

8.

Differences in accumulation and the transport mechanism of l- and d-methionine in high- and low-grade human glioma cells.

Kobayashi M, Mizutani A, Nishi K, Nakajima S, Shikano N, Nishii R, Fukuchi K, Kawai K.

Nucl Med Biol. 2017 Jan;44:78-82. doi: 10.1016/j.nucmedbio.2016.09.003. Epub 2016 Sep 14.

PMID:
27835793
9.

Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.

Inano R, Oishi N, Kunieda T, Arakawa Y, Yamao Y, Shibata S, Kikuchi T, Fukuyama H, Miyamoto S.

Neuroimage Clin. 2014 Aug 7;5:396-407. doi: 10.1016/j.nicl.2014.08.001. eCollection 2014.

10.

Evaluation of glucose transport in malignant glioma by PET.

Ishikawa M, Kikuchi H, Nishizawa S, Yonekura Y.

Acta Neurochir Suppl (Wien). 1990;51:165-7.

PMID:
2089886
11.

Occupational exposure to low frequency magnetic fields and the risk of low grade and high grade glioma.

Karipidis KK, Benke G, Sim MR, Yost M, Giles G.

Cancer Causes Control. 2007 Apr;18(3):305-13. Epub 2007 Jan 27.

PMID:
17260179
12.

Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

Floeth FW, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider MJ, Jansen P, Coenen HH, Steiger HJ, Langen KJ.

J Nucl Med. 2007 Apr;48(4):519-27.

13.

Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.

Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M.

Strahlenther Onkol. 2003 Sep;179(9):585-97. Review.

PMID:
14628124
14.

Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.

Rebetz J, Tian D, Persson A, Widegren B, Salford LG, Englund E, Gisselsson D, Fan X.

PLoS One. 2008 Apr 9;3(4):e1936. doi: 10.1371/journal.pone.0001936.

15.

Image guided surgery for the resection of brain tumours.

Barone DG, Lawrie TA, Hart MG.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD009685. doi: 10.1002/14651858.CD009685.pub2. Review.

PMID:
24474579
16.

The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Ryken TC, Parney I, Buatti J, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):551-83. doi: 10.1007/s11060-015-1948-1. Epub 2015 Nov 3. Review.

PMID:
26530266
17.

Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003.

Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P.

Eur Arch Psychiatry Clin Neurosci. 2006 Dec;256(8):516-21. Epub 2006 Sep 7.

PMID:
16960653
18.

Risk assessment in paediatric glioma-Time to move on from the binary classification.

Dodgshun AJ, Hansford JR, Sullivan MJ.

Crit Rev Oncol Hematol. 2017 Mar;111:52-59. doi: 10.1016/j.critrevonc.2017.01.012. Epub 2017 Jan 23. Review.

PMID:
28259295
19.

High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.

Xu T, Qin R, Zhou J, Yan Y, Lu Y, Zhang X, Fu D, Lv Z, Li W, Xia C, Hu G, Ding X, Chen J.

PLoS One. 2012;7(10):e48415. doi: 10.1371/journal.pone.0048415. Epub 2012 Oct 31.

20.

[Histological and molecular classification of gliomas].

Figarella-Branger D, Colin C, Coulibaly B, Quilichini B, Maues De Paula A, Fernandez C, Bouvier C.

Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):505-15. doi: 10.1016/j.neurol.2008.03.011. Epub 2008 Jun 10. Review. French.

PMID:
18565348

Supplemental Content

Support Center